Kontny E, Lewandowska-Poluch A, Chmielińska M, Olesińska M (2018) Subgroups of Sjögren’s syndrome patients categorised by serological profiles. Clin Immunol Char 56:346–353

Google Scholar 

Jeon HS, Youn SW, Jeon HE, Kim JH, Hyon JY (2016) Assessment of transepidermal water loss from the ocular area in dry eye disease. Invest Ophthalmol Vis Sci 57:4831–4836. https://doi.org/10.1167/iovs.16-20109

Article  PubMed  Google Scholar 

Coursey TG, de Paiva CS (2014) Managing Sjögren’s Syndrome and non-Sjögren syndrome dry eye with anti-inflammatory therapy. Clinical ophthalmology (Auckland, NZ) 8:1447–1458. https://doi.org/10.2147/OPTH.S35685

CAS  Article  Google Scholar 

Baer AN, McAdams DeMarco M, Shiboski SC, Lam MY, Challacombe S, Daniels TE, Dong Y, Greenspan JS, Kirkham BW, Lanfranchi HE, Schiodt M, Srinivasan M, Umehara H, Vivino FB, Vollenweider CF, Zhao Y, Criswell LA, Shiboski CH (2015) The SSB-positive/SSA-negative antibody profile is not associated with key phenotypic features of Sjogren’s syndrome. Ann Rheum Dis 74:1557–1561. https://doi.org/10.1136/annrheumdis-2014-206683

CAS  Article  PubMed  Google Scholar 

Ben-Chetrit E, Fischel R, Rubinow A (1993) Anti-SSA/Ro and anti-SSB/La antibodies in serum and saliva of patients with Sjogren’s syndrome. Clin Rheumatol 12:471–474. https://doi.org/10.1007/bf02231773

CAS  Article  PubMed  Google Scholar 

Horsfall AC, Rose LM, Maini RN (1989) Autoantibody synthesis in salivary glands of Sjögren’s syndrome patients. J Autoimmun 2:559–568. https://doi.org/10.1016/0896-8411(89)90189-3

CAS  Article  PubMed  Google Scholar 

Tan EM (1989) Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 44:93–151. https://doi.org/10.1016/s0065-2776(08)60641-0

CAS  Article  PubMed  Google Scholar 

Routsias JG, Tzioufas AG (2010) Autoimmune response and target autoantigens in Sjogren’s syndrome. Eur J Clin Invest 40:1026–1036. https://doi.org/10.1111/j.1365-2362.2010.02342.x

CAS  Article  PubMed  Google Scholar 

Bournia VK, Vlachoyiannopoulos PG (2012) Subgroups of Sjögren syndrome patients according to serological profiles. J Autoimmun 39:15–26. https://doi.org/10.1016/j.jaut.2012.03.001

Article  PubMed  Google Scholar 

Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X (2017) 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjogren’s syndrome: A consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis 76:9–16. https://doi.org/10.1136/annrheumdis-2016-210571

Article  PubMed  Google Scholar 

Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, Schiødt M, Umehara H, Vivino F, Zhao Y, Dong Y, Greenspan D, Heidenreich AM, Helin P, Kirkham B, Kitagawa K, Larkin G, Li M, Lietman T, Lindegaard J, McNamara N, Sack K, Shirlaw P, Sugai S, Vollenweider C, Whitcher J, Wu A, Zhang S, Zhang W, Greenspan J, Daniels T (2012) American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 64:475–487. https://doi.org/10.1002/acr.21591

CAS  Article  Google Scholar 

Lim SA, Nam S, Kwok SK, Park SH, Chung SH (2015) Serologic markers are associated with ocular staining score in primary Sjogren syndrome. Cornea 34:1466–1470. https://doi.org/10.1097/ico.0000000000000612

Article  PubMed  Google Scholar 

Chung JK, Kim MK, Wee WR (2012) Prognostic factors for the clinical severity of keratoconjunctivitis sicca in patients with Sjogren’s syndrome. Br J Ophthalmol 96:240–245. https://doi.org/10.1136/bjo.2011.202812

Article  PubMed  Google Scholar 

Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL (2000) Reliability and validity of the ocular surface disease index. Arch Ophthalmol 118:615–621. https://doi.org/10.1001/archopht.118.5.615

CAS  Article  PubMed  Google Scholar 

Vitale S, Goodman LA, Reed GF, Smith JA (2004) Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sjögren’s syndrome-related dry eye. Health Qual Life Outcomes 2:44. https://doi.org/10.1186/1477-7525-2-44

Article  PubMed  PubMed Central  Google Scholar 

Oliveira HF, de Souza TR, Carvalho CN, Duarte A, Carvalho AT, Leao JC, Gueiros LA (2015) Serologic profile and clinical markers of Sjogren syndrome in patients with rheumatoid arthritis. Oral Surg Oral Med Oral Pathol Oral Radiol 119:628–635. https://doi.org/10.1016/j.oooo.2015.02.479

Article  PubMed  Google Scholar 

Toker E, Yavuz S, Direskeneli H (2004) Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjogren’s syndrome. Br J Ophthalmol 88:384–387

CAS  Article  Google Scholar 

Katsifis GE, Rekka S, Moutsopoulos NM et al (2009) Systemic and local interleukin-17 and linked cytokines associated with Sjogren’s syndrome immunopathogenesis. Am J Pathol 175:1167–1177

CAS  Article  Google Scholar 

Candon S, Gottenberg JE, Bengoufa D et al (2009) Quantitative assessment of antibodies to ribonucleoproteins in primary Sjogren syndrome: correlation with B-cell biomarkers and disease activity. Ann Rheum Dis 68:1208–1212

CAS  Article  Google Scholar 

Yang S, Lee HJ, Kim DY, Shin S, Barabino S, Chung SH (2019) The use of conjunctival staining to measure ocular surface inflammation in patients with dry eye. Cornea 38:698–705. https://doi.org/10.1097/ico.0000000000001916

Article  PubMed  Google Scholar 

Oh JY, Kim MK, Choi HJ, Ko JH, Kang EJ, Lee HJ, Wee WR, Lee JH (2011) Investigating the relationship between serum interleukin-17 levels and systemic immune-mediated disease in patients with dry eye syndrome. Korean J Ophthalmol 25:73–76. https://doi.org/10.3341/kjo.2011.25.2.73

CAS  Article  PubMed  PubMed Central  Google Scholar 

Menzies KL, Srinivasan S, Prokopich CL, Jones L (2015) Infrared imaging of meibomian glands and evaluation of the lipid layer in Sjögren’s syndrome patients and nondry eye controls. Invest Ophthalmol Vis Sci 56:836–841. https://doi.org/10.1167/iovs.14-13864

Article  PubMed  Google Scholar 

Kang YS, Lee HS, Li Y, Choi W, Yoon KC (2018) Manifestation of meibomian gland dysfunction in patients with Sjogren’s syndrome, non-Sjogren’s dry eye, and non-dry eye controls. Int Ophthalmol 38:1161–1167. https://doi.org/10.1007/s10792-017-0577-4

Article  PubMed  Google Scholar 

Sullivan DA, Dana R, Sullivan RM, Krenzer KL, Sahin A, Arica B, Liu Y, Kam WR, Papas AS, Cermak JM (2018) Meibomian gland dysfunction in primary and secondary Sjögren syndrome. Ophthalmic Res 59:193–205. https://doi.org/10.1159/000487487

Article  PubMed  Google Scholar 

Zang S, Cui Y, Cui Y, Fei W (2018) Meibomian gland dropout in Sjögren’s syndrome and non-Sjögren’s dry eye patients. Eye (Lond) 32:1681–1687. https://doi.org/10.1038/s41433-018-0149-5

Article  Google Scholar 

Cornaby C, Gibbons L, Mayhew V, Sloan CS, Welling A, Poole BD (2015) B cell epitope spreading: Mechanisms and contribution to autoimmune diseases. Immunol Lett 163:56–68. https://doi.org/10.1016/j.imlet.2014.11.001

CAS  Article  PubMed  Google Scholar